Zealand Pharma ROE - Return on Equity 2017-2024 | ZLDPF

Zealand Pharma return on equity for the quarter ending June 30, 2024 was -18.01.

  • Zealand Pharma average return on equity for 2023 was -104.1, a 31.57% decline from 2022.
  • Zealand Pharma average return on equity for 2022 was -152.12, a 105.23% decline from 2021.
  • Zealand Pharma average return on equity for 2021 was -74.12, a 51.17% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Zealand Pharma ROE - Return on Equity 2017-2024 | ZLDPF

  • Zealand Pharma average return on equity for 2023 was -104.1, a 31.57% decline from 2022.
  • Zealand Pharma average return on equity for 2022 was -152.12, a 105.23% decline from 2021.
  • Zealand Pharma average return on equity for 2021 was -74.12, a 51.17% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.